IL10, IL11, IL18 are differently expressed in CD14 + TAMs and play different role in regulating the invasion of gastric cancer cells under hypoxia

Cytokine

Volumn 59, Issue 2, 2012, Pages 352-357

  Shen, Zhanlong ^a,b   Seppänen, Hanna ^b   Vainionpää, Sanna ^b   Ye, Yingjiang ^a   Wang, Shan ^a   Mustonen, Harri ^b   Puolakkainen, Pauli ^b  

^a PEKING UNIVERSITY PEOPLE S HOSPITAL   (China)

^b HELSINKI UNIVERSITY CENTRAL HOSPITAL   (Finland)

Author keywords

Gastric cancer; Interleukin 10 (IL10); Interleukin 11 (IL11); Interleukin 18 (IL18); Tumor associated macrophages (TAMs)

Indexed keywords

CD14 ANTIGEN; INTERLEUKIN 10; INTERLEUKIN 11; INTERLEUKIN 18; MATRIGEL;

ARTICLE; CANCER CELL CULTURE; CELL HYPOXIA; CELL INVASION; COCULTURE; CONTROLLED STUDY; DISTANT METASTASIS; HUMAN; HUMAN CELL; PRIORITY JOURNAL; PROTEIN EXPRESSION; QUANTITATIVE ANALYSIS; REAL TIME POLYMERASE CHAIN REACTION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; STOMACH CANCER; TUMOR ASSOCIATED LEUKOCYTE; UPREGULATION;

ANTIGENS, CD14; CELL HYPOXIA; CELL LINE, TUMOR; CELL MOVEMENT; COCULTURE TECHNIQUES; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; INTERLEUKIN-10; INTERLEUKIN-11; INTERLEUKIN-18; INTERLEUKINS; MACROPHAGES; NEOPLASM INVASIVENESS; STOMACH NEOPLASMS;

EID: 84862304846     PISSN: 10434666     EISSN: 10960023     Source Type: Journal    
DOI: 10.1016/j.cyto.2012.04.033     Document Type: Article

References (37)

1. Lin W.W., Karin M. A cytokine-mediated link between innate immunity inflammation and cancer. J Clin Invest 2007, 117:1175-1183.
2. Balkwill F., Charles K.A., Mantovani A. Smoldering and polarized inflammation in the initiation and promotion of malignant disease. Cancer Cell 2005, 7:211-217.
3. Qian B.Z., Pollard J.W. Macrophage diversity enhances tumor progression and metastasis. Cell 2010, 141(2):39-51.
4. Biswas S.K., Sica A., Lewis C.E. Plasticity of macrophage function during tumor progression: regulation by distinct molecular mechanisms. J Immunol 2008, 180:2011-2017.
5. Condeelis J., Segall J.E. Intravital imaging of cell movement in tumours. Nat Rev Cancer 2003, 3:921-930.
6. Hanada T., Nakagawa M., Emoto A., Nomura T., Nasu N., Nomura Y. Prognostic value of tumor-associated macrophage count in human bladder cancer. Int J Urol 2000, 7:263-269.
7. Salvesen H.B., Akslen L.A. Significance of tumor-associated macrophages vascular endothelial growth factor and thrombospondin-1 expression for tumor angiogenesis and prognosis in endometrial carcinomas. Int J Cancer 1999, 84:538-543.
8. Vaupel P., Kelleher D.K., Hockel M. Oxygen status of malignant tumors: pathogenesis of hypoxia and significance for tumor therapy. Semin Oncol 2001, 28:29-35.
9. Burke B., Giannoudis A., Corke K.P., Gill D., Wells M., Ziegler-Heitbrock L. Hypoxia-induced gene expression in human macrophages: implications for ischemic tissues and hypoxia-regulated gene therapy. Am J Pathol 2003, 163:1233-1243.
10. Ohno S., Ohno Y., Suzuki N., Kamei T., Koike K., Inagawa H., et al. Correlation of histological localization of tumor associated macrophages with clinicopathological features in endometrial cancer. Anticancer Res 2004, 24:3335-3342.
11. Negus R.P., Stamp G.W., Hadley J., Balkwill F.R. Quantitative assessment of the leukocyte infiltrate in ovarian cancer and its relationship to the expression of C-C chemokines. Am J Pathol 1997, 150:1723-1734.
12. Murdock C., Giannoudis A., Lewis C.E. Mechanisms regulating the recruitment of macrophages into hypoxic areas of tumors and other ischemic tissues. Blood 2004, 104:2224-2234.
13. Sica A., Saccani A., Bottazzi B., Polentarutti N., Vecchi A., van Damme J. Autocrine production of IL-10 mediates defective IL-12 production and NF-kappaB activation in tumor-associated macrophages. J Immunol 2000, 164:762-767.
14. Hagemann T., Biswas S.K., Lawrence T., Sica A., Lewis C.E. Regulation of macrophage function in tumors: the multifaceted role of NF-kappaB. Blood 2009, 113:3139-3146.
15. Yue F.Y., Dummer R., Geertsen R., et al. Interleukin-10 is a growth factor for human melanoma cells and down regulates HLA class-I HLA class-II and ICAM-1 molecules. Int J Cancer 1997, 71:630-637.
16. Hatanaka H., Abe Y., Kamiya T., et al. Clinical implications of interleukin (IL)-10 induced by non-small-cell lung cancer. Ann Oncol 2000, 11:815-819.
17. Soria J.C., Moon C., Kemp B.L., et al. Lack of interleukin-10 expression could predict poor outcome in patients with stage I non-small cell lung cancer. Clin Cancer Res 2003, 9:1785-1791.
18. Dace D.S., Khan A.A., Kelly J., Apte R.S. Interleukin-10 promotes pathological angiogenesis by regulating macrophage response to hypoxia during development. PLoS One 2008, 3:e3381.
19. Nakayama T., Yoshizaki A., Izumida S., Suehiro T., Miura S., Uemura T. Expression of interleukin-11 (IL-11) and IL-11 receptor alpha in human gastric carcinoma and IL-11 upregulates the invasive activity of human gastric carcinoma cells. Int J Oncol 2007, 30:825-833.
20. Jackson C.B., Judd L.M., Menheniott T.R., Kronborg I., Dow C., Yeomans N.D. Augmented gp130-mediated cytokine signalling accompanies human gastric cancer progression. J Pathol 2007, 213:140-151.
21. Howlett M., Giraud A.S., Lescesen H., Jackson C.B., Kalantzis A., Van Driel I.R. The interleukin-6 family cytokine interleukin-11 regulates homeostatic epithelial cell turnover and promotes gastric tumor development. Gastroenterology 2009, 136:967-977.
22. Majima T., Ichikura T., Chochi K., Kawabata T., Tsujimoto H., Sugasawa H. Exploitation of interleukin-18 by gastric cancers for their growth and evasion of host immunity. Int J Cancer 2006, 118:388-395.
23. Kawabata T., Ichikura T., Majima T., Seki S., Chochi K., Takayama E. Cancer 2001, 92:2050-2055.
24. Majima T., Ichikura T., Seki S., Takayama E., Matsumoto A., Kawabata T. The influence of interleukin-10 and interleukin-18 on interferon-gamma production by peritoneal exudate cells in patients with gastric carcinoma. Anticancer Res 2002, 22:1193-1199.
25. Mantovani A., Sozzani S., Locati M., Allavena P., Sica A. Macrophage polarization: tumor-associated macrophages as a paradigm for polarized M2 mononuclear phagocytes. Trends Immunol 2002, 23:549-555.
26. http://www.iarc.fr/en/publications/pdfs-online/wcr/2008/index.php.
27. Parkin D.M., Bray F., Ferlay J., Pisani P. Global cancer statistics 2002, CA. Cancer J Clin 2005, 55:74-108.
28. http://seer.cancer.gov/csr/1975_2007/results_merged/topic_survival.pdf.
29. Lawrence T. Inflammation and cancer: a failure of resolution? Trends. Pharmacol Sci 2007, 28:162-165.
30. Parsonnet J., Friedman G.D., Vandersteen D.P., Chang Y., Vogelman J.H., Orentreich N. Helicobacter pylori infection and the risk of gastric carcinoma. N Engl J Med 1991, 325:1127-1131.
31. Nardin A., Abastado J.P. Macrophages and cancer. Front Biosci 2008, 13:3494-3505.
32. Sica A., Larghi P., Mancino A., Rubino L., Porta C., Totaro M.G. Macrophage polarization in tumour progression. Semin Cancer Biol 2008, 18:349-355.
33. Thong-Ngam D., Tangkijvanich P., Lerknimitr R., Mahachai V., Theamboonelrs A., Poovorawan Y. Diagnostic role of serum interleukin-18 in gastric cancer patients. World J Gastroenterol 2006, 12:4473-4477.
34. Szaflarska A., Szczepanik A., Siedlar M., Czupryna A., Sierzega M., Popiela T. Preoperative plasma level of IL-10 but not of proinflammatory cytokines is an independent prognostic factor in patients with gastric cancer. Anticancer Res 2009, 29:5005-5012.
35. Espey M.G. Tumor macrophage redox and effector mechanisms associated with hypoxia. Free Radic Biol Med 2006, 41:1621-1628.
36. Doedens A.L., Stockmann C., Rubinstein M.P., Liao D., Zhang N., DeNardo D.G. Macrophage expression of hypoxia-inducible factor-1 alpha suppresses T-cell function and promotes tumor progression. Cancer Res 2010, 70:7465-7475.
37. Kim J., Shao Y., Kim S.Y., Kim S., Song H.K., Jeon J.H. Hypoxia-induced IL-18 increases hypoxia-inducible factor-1alpha expression through a Rac1-dependent NF-kappaB pathway. Mol Biol Cell 2008, 19:433-444.